789 related articles for article (PubMed ID: 24934335)
41. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
Tuon FF; Rigatto MH; Lopes CK; Kamei LK; Rocha JL; Zavascki AP
Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
[TBL] [Abstract][Full Text] [Related]
42. Incidence of Acute Kidney Injury Among Patients Receiving the Combination of Vancomycin with Piperacillin-Tazobactam or Meropenem.
Robertson AD; Li C; Hammond DA; Dickey TA
Pharmacotherapy; 2018 Dec; 38(12):1184-1193. PubMed ID: 30175410
[TBL] [Abstract][Full Text] [Related]
43. Vancomycin Prescribing and Therapeutic Drug Monitoring in Children With and Without Acute Kidney Injury After Cardiac Arrest.
Fitzgerald JC; Zane NR; Himebauch AS; Reedy MD; Downes KJ; Topjian AA; Furth SL; Thomas NJ; Scheetz MH; Zuppa AF
Paediatr Drugs; 2019 Apr; 21(2):107-112. PubMed ID: 30864056
[TBL] [Abstract][Full Text] [Related]
44. Late-Occurring Vancomycin-Associated Acute Kidney Injury in Children Receiving Prolonged Therapy.
Knoderer CA; Gritzman AL; Nichols KR; Wilson AC
Ann Pharmacother; 2015 Oct; 49(10):1113-9. PubMed ID: 26160972
[TBL] [Abstract][Full Text] [Related]
45. Piperacillin/Tazobactam and Antibiotic-Associated Acute Kidney Injury in Critically Ill Children.
Joyce EL; Kane-Gill SL; Priyanka P; Fuhrman DY; Kellum JA
J Am Soc Nephrol; 2019 Nov; 30(11):2243-2251. PubMed ID: 31501354
[TBL] [Abstract][Full Text] [Related]
46. Validation of the KDIGO acute kidney injury criteria in a pediatric critical care population.
Selewski DT; Cornell TT; Heung M; Troost JP; Ehrmann BJ; Lombel RM; Blatt NB; Luckritz K; Hieber S; Gajarski R; Kershaw DB; Shanley TP; Gipson DS
Intensive Care Med; 2014 Oct; 40(10):1481-8. PubMed ID: 25079008
[TBL] [Abstract][Full Text] [Related]
47. Effect of concomitant vancomycin and piperacillin-tazobactam on frequency of acute kidney injury in pediatric patients.
Buhlinger KM; Fuller KA; Faircloth CB; Wallace JR
Am J Health Syst Pharm; 2019 Aug; 76(16):1204-1210. PubMed ID: 31369115
[TBL] [Abstract][Full Text] [Related]
48. Acute kidney injury during daptomycin versus vancomycin treatment in cardiovascular critically ill patients: a propensity score matched analysis.
Gaudard P; Saour M; Morquin D; David H; Eliet J; Villiet M; Daures JP; Colson P
BMC Infect Dis; 2019 May; 19(1):438. PubMed ID: 31109283
[TBL] [Abstract][Full Text] [Related]
49. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study.
Kane-Gill SL; Sileanu FE; Murugan R; Trietley GS; Handler SM; Kellum JA
Am J Kidney Dis; 2015 Jun; 65(6):860-9. PubMed ID: 25488106
[TBL] [Abstract][Full Text] [Related]
50. Community-acquired Acute Kidney Injury Among Children Seen in the Pediatric Emergency Department.
Bernardo EO; Cruz AT; Buffone GJ; Devaraj S; Loftis LL; Arikan AA
Acad Emerg Med; 2018 Jul; 25(7):758-768. PubMed ID: 29630763
[TBL] [Abstract][Full Text] [Related]
51. Incidence of Acute Kidney Injury Among Critically Ill Patients With Brief Empiric Use of Antipseudomonal β-Lactams With Vancomycin.
Schreier DJ; Kashani KB; Sakhuja A; Mara KC; Tootooni MS; Personett HA; Nelson S; Rule AD; Steckelberg JM; Tande AJ; Barreto EF
Clin Infect Dis; 2019 Apr; 68(9):1456-1462. PubMed ID: 30165426
[TBL] [Abstract][Full Text] [Related]
52. Early renal replacement therapy during pediatric cardiac extracorporeal support increases mortality.
Wolf MJ; Chanani NK; Heard ML; Kanter KR; Mahle WT
Ann Thorac Surg; 2013 Sep; 96(3):917-22. PubMed ID: 23915590
[TBL] [Abstract][Full Text] [Related]
53. Risk factors for surgical site infection in pediatric cardiac surgery patients undergoing delayed sternal closure.
Harder EE; Gaies MG; Yu S; Donohue JE; Hanauer DA; Goldberg CS; Hirsch JC
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):326-33. PubMed ID: 23102685
[TBL] [Abstract][Full Text] [Related]
54. Acute Kidney Injury in Patients Treated with IV Beta-Lactam/Beta-Lactamase Inhibitor Combinations.
Rutter WC; Burgess DS
Pharmacotherapy; 2017 May; 37(5):593-598. PubMed ID: 28247443
[TBL] [Abstract][Full Text] [Related]
55. Risk factors for kidney injury during vancomycin and piperacillin/tazobactam administration, including increased odds of injury with combination therapy.
Kim T; Kandiah S; Patel M; Rab S; Wong J; Xue W; Easley K; Anderson AM
BMC Res Notes; 2015 Oct; 8():579. PubMed ID: 26476979
[TBL] [Abstract][Full Text] [Related]
56. Diabetes mellitus does not affect the incidence of acute kidney injury after cardiac surgery; a nested case-control study.
Moschopoulou M; Ampatzidou FC; Loutradis C; Boutou A; Koutsogiannidis CP; Drosos GE; Sarafidis PA
J Nephrol; 2016 Dec; 29(6):835-845. PubMed ID: 26924544
[TBL] [Abstract][Full Text] [Related]
57. Acute kidney injury in neonatal intensive care: Medicines involved.
Safina AI; Daminova MA; Abdullina GA
Int J Risk Saf Med; 2015; 27 Suppl 1():S9-S10. PubMed ID: 26639729
[TBL] [Abstract][Full Text] [Related]
58. Personnel and unit factors impacting outcome after cardiac arrest in a dedicated pediatric cardiac intensive care unit.
Gaies MG; Clarke NS; Donohue JE; Gurney JG; Charpie JR; Hirsch JC
Pediatr Crit Care Med; 2012 Sep; 13(5):583-8. PubMed ID: 22079956
[TBL] [Abstract][Full Text] [Related]
59. Incidence of Nephrotoxicity Among Pediatric Patients Receiving Vancomycin With Either Piperacillin-Tazobactam or Cefepime: A Cohort Study.
Cook KM; Gillon J; Grisso AG; Banerjee R; Jimenez-Truque N; Phillips EJ; Van Driest SL
J Pediatric Infect Dis Soc; 2019 Jul; 8(3):221-227. PubMed ID: 29590376
[TBL] [Abstract][Full Text] [Related]
60. Risk Factors of Acute Kidney Injury in Critically Ill Children.
Slater MB; Gruneir A; Rochon PA; Howard AW; Koren G; Parshuram CS
Pediatr Crit Care Med; 2016 Sep; 17(9):e391-8. PubMed ID: 27472255
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
